Wednesday, September 7th, 2011
Physicians and patient groups welcome the National Institute for Health and Clinical Excellence (NICE) decision to reverse the draft guidance and approve the use of use of Mepact® in their latest appraisal, announced Takeda UK. Mepact® is designed to treat high-grade non-metastatic osteosarcoma in children, adolescents and young adults aged ...
Posted in Health | Comments Off
Thursday, August 25th, 2011
Revolutionary new guidelines for diagnosing and treating blood pressure for the medical profession have been issued by NICE and developed in corporation with the British Hypertension Society (BHS). For the first time in over a century, GP's routine to monitor blood pressure has been changed. A significant change ...
Posted in Health | Comments Off
Saturday, August 6th, 2011
In a draft decision, Britain's independent body that recommends whether drugs should be covered by the National Health Service, decided that at £20,000 a year fingolimod "would not be a cost effective use of NHS resources." Thousands of multiple sclerosis sufferers who do not respond to current medications were disappointed. ...
Posted in Health | Comments Off
Friday, July 15th, 2011
NICE (National Institute for Clinical Excellence) in the UK has decided not to recommend Lucentis (ranibizumab) for diabetic macular edema (British spelling: oedema) treatment. NICE approves or turns down treatments that will be covered by the NHS (National Health Service), the UK's universal health care system. Patients will still be ...
Posted in Health | Comments Off
Wednesday, April 27th, 2011
The National Institute for Health and Clinical Excellence (NICE) has today issued final guidance recommending golimumab (Simponi) for the treatment of psoriatic arthritis. Golimumab joins a list of treatment options already recommended by NICE for this condition. The guidance recommends golimumab as an option for treating active and progressive psoriatic ...
Posted in Health | Comments Off
